title: Polyanalgesic Consensus Conference--2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain.
abstract: BACKGROUND
  Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options fail. This therapy is well established in the literature, has shown efficacy, and is an important tool for the treatment of both cancer and noncancer pain; however, it has become clear in recent years that intrathecal drug delivery is associated with risks for serious morbidity and mortality.
  
  
  METHODS
  The Polyanalgesic Consensus Conference is a meeting of experienced implanting physicians who strive to improve care in those receiving implantable devices. Employing data generated through an extensive literature search combined with clinical experience, this work group formulated recommendations regarding awareness, education, and mitigation of the morbidity and mortality associated with intrathecal therapy to establish best practices for targeted intrathecal drug delivery systems.
  
  
  RESULTS
  Best practices for improved patient care and outcomes with targeted intrathecal infusion are recommended to minimize the risk of morbidity and mortality. Areas of focus include respiratory depression, infection, granuloma, device-related complications, endocrinopathies, and human error. Specific guidance is given with each of these issues and the general use of the therapy.
  
  
  CONCLUSIONS
  Targeted intrathecal drug delivery systems are associated with risks for morbidity and mortality that can be devastating. The panel has given guidance to treating physicians and healthcare providers to reduce the incidence of these problems and to improve outcomes when problems occur.
authors: Center for Pain Relief, Charleston, WV 25301, USA. doctdeer@aol.com
authors: Timothy R
authors: TR
authors: Deer
authors: Robert
authors: R
authors: Levy
authors: Joshua
authors: J
authors: Prager
authors: Eric
authors: E
authors: Buchser
authors: Allen
authors: A
authors: Burton
authors: David
authors: D
authors: Caraway
authors: Michael
authors: M
authors: Cousins
authors: José
authors: J
authors: De Andrés
authors: Sudhir
authors: S
authors: Diwan
authors: Michael
authors: M
authors: Erdek
authors: Eric
authors: E
authors: Grigsby
authors: Marc
authors: M
authors: Huntoon
authors: Marilyn S
authors: MS
authors: Jacobs
authors: Philip
authors: P
authors: Kim
authors: Krishna
authors: K
authors: Kumar
authors: Michael
authors: M
authors: Leong
authors: Liong
authors: L
authors: Liem
authors: Gladstone C
authors: GC
authors: McDowell
authors: Sunil
authors: S
authors: Panchal
authors: Richard
authors: R
authors: Rauck
authors: Michael
authors: M
authors: Saulino
authors: B Todd
authors: BT
authors: Sitzman
authors: Peter
authors: P
authors: Staats
authors: Michael
authors: M
authors: Stanton-Hicks
authors: Lisa
authors: L
authors: Stearns
authors: Mark
authors: M
authors: Wallace
authors: K Dean
authors: KD
authors: Willis
authors: William
authors: W
authors: Witt
authors: Tony
authors: T
authors: Yaksh
authors: Nagy
authors: N
authors: Mekhail
mesh_terms: D000700:Analgesics / Q000008:administration & dosage*; D059350:Chronic Pain / Q000188:drug therapy* / Q000401:mortality; D016503:Drug Delivery Systems / Q000379:methods / Q000592:standards*; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000592:standards*; D007278:Injections, Spinal / Q000379:methods / Q000592:standards*
chemical_list: D000700:Analgesics